DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting | MicrobiomeTrials← Back to trialsNCT07358078
DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-01-09Est. Completion: 2030-10-23
Enrollment target: 2,000 participants Locations- Clinical Trial Site, Tucson, Arizona, United States
- Clinical Trial Site, Beverly Hills, California, United States
- Clinical Trial Site, Naples, Florida, United States
- Clinical Trial Site, Kansas City, Kansas, United States
- Clinical Trial Site, Boston, Massachusetts, United States
- Clinical Trial Site, St Louis, Missouri, United States
- Clinical Trial Site, New Brunswick, New Jersey, United States
- Clinical Trial Site, Charlotte, North Carolina, United States
- Clinical Trial Site, Philadelphia, Pennsylvania, United States
- Clinical Trial Site, Memphis, Tennessee, United States
- Clinical Trial Site, Dallas, Texas, United States
- Clinical Trial Site, Heidelberg, Germany
- Clinical Trial Site, Munich, Germany
- Clinical Trial Site, Münster, Germany
- Clinical Trial Site, Bunkyō City, Japan
- Clinical Trial Site, Kumamoto, Japan
- Clinical Trial Site, Kurume, Japan
- Clinical Trial Site, Matsumoto, Japan
Other microbiome trials you might be interested in
Transthyretin Amyloid Cardiomyopathy
Transthyretin (TTR) is a protein made by the liver that helps transport thyroid hormone and vitamin A in the blood. In s…
Sankt Pölten, AustriaEst. completion Jul 15, 2027
ATTR Amyloidosis
The overall aim of this observational study is to generate real-world evidence on the pre- and post-diagnosis disease jo…
Eden Prairie, United StatesEst. completion Nov 2, 2026
Clinical Trial Site, Sendai, JapanClinical Trial Site, Shinjuku, JapanClinical Trial Site, Suita, JapanClinical Trial Site, Tsukuba, JapanClinical Trial Site, Ube, JapanClinical Trial Site, Yufu, Japan